Recent Updates on Corticosteroid Resistance in Asthma

European Medical Journal Allergy & Immunology

article

Lipsa Panda¹  Ulaganathan Mabalirajan¹ 

[1] Molecular Pathobiology of Respiratory Diseases, Council of Scientific & Industrial Research ,(CSIR), Institute of Genomics and Integrative Biology

关键词: Asthma;    glucocorticoids (GC);    glucocorticoid receptor (GR);    steroid resistance;   

DOI  :  10.33590/emj/10311987

学科分类：社会科学、人文和艺术（综合）

来源: European Medical Journal

【 摘 要 】

Corticosteroids are one of the most effective medications available for a wide variety of inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, autoimmune diseases, and chronic lung diseases such as asthma; however, 5–10% of asthma patients respond poorly to corticosteroids and require high doses, secondary immunosuppressants, such as calcineurin inhibitors and methotrexate, or disease-modifying biologics that can be toxic and/or expensive. Though steroid-resistant asthma affects a small percentage of patients, it consumes significant health resources and contributes to substantial morbidity and mortality. In addition, the side effects caused by excessive use of steroids dramatically impact patients’ quality of life. Recognition of patients who respond poorly to steroid therapy is important due to the persistent and considerable problems they face in managing their conditions, which bears a significant socioeconomic burden. Along with the recognition of such patients, elucidation of the molecular mechanisms of steroid resistance is equally important, so that administration of a high dosage of steroids, and the consequent adverse effects, can be avoided. This review provides an update on the mechanisms of steroid function and the possible new therapeutic modalities to treat steroid-resistant asthma.

【 授权许可】

CC BY-NC